495 related articles for article (PubMed ID: 25364233)
21. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
Noel S; Zheng L; Navas-Acien A; Fuchs RJ
Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
[TBL] [Abstract][Full Text] [Related]
22. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
[TBL] [Abstract][Full Text] [Related]
23. Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment.
Wang YY; Zhe H; Zhao R
Mol Cancer; 2014 Feb; 13():30. PubMed ID: 24552536
[TBL] [Abstract][Full Text] [Related]
24. Efficient and scalable synthesis of bardoxolone methyl (cddo-methyl ester).
Fu L; Gribble GW
Org Lett; 2013 Apr; 15(7):1622-5. PubMed ID: 23530743
[TBL] [Abstract][Full Text] [Related]
25. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
[TBL] [Abstract][Full Text] [Related]
26. Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.
Ahmad R; Raina D; Meyer C; Kufe D
Cancer Res; 2008 Apr; 68(8):2920-6. PubMed ID: 18413761
[TBL] [Abstract][Full Text] [Related]
27. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
[TBL] [Abstract][Full Text] [Related]
28. CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus.
Kim JE; Park H; Lee JE; Kang TC
Cells; 2020 May; 9(5):. PubMed ID: 32370011
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent.
Deeb D; Gao X; Liu YB; Gautam SC
J Exp Ther Oncol; 2012; 10(1):51-64. PubMed ID: 22946344
[TBL] [Abstract][Full Text] [Related]
30. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
Aminzadeh MA; Reisman SA; Vaziri ND; Khazaeli M; Yuan J; Meyer CJ
Xenobiotica; 2014 Jun; 44(6):570-8. PubMed ID: 24195589
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.
Nagaraj S; Youn JI; Weber H; Iclozan C; Lu L; Cotter MJ; Meyer C; Becerra CR; Fishman M; Antonia S; Sporn MB; Liby KT; Rawal B; Lee JH; Gabrilovich DI
Clin Cancer Res; 2010 Mar; 16(6):1812-23. PubMed ID: 20215551
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors.
Speranza G; Gutierrez ME; Kummar S; Strong JM; Parker RJ; Collins J; Yu Y; Cao L; Murgo AJ; Doroshow JH; Chen A
Cancer Chemother Pharmacol; 2012 Feb; 69(2):431-8. PubMed ID: 21805353
[TBL] [Abstract][Full Text] [Related]
34. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro.
Chi YL; Xie Y; Liu SQ; Zhu WY
Virol J; 2023 Nov; 20(1):258. PubMed ID: 37950261
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs.
Liu L; Pan X; Xie F; Xu X; Xiao D; Xiao J; Zhou X
Bioorg Chem; 2022 Jul; 124():105831. PubMed ID: 35512420
[TBL] [Abstract][Full Text] [Related]
36. Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD).
Impellizzeri D; Esposito E; Attley J; Cuzzocrea S
Pharmacol Res; 2014 Mar; 81():91-102. PubMed ID: 24602801
[TBL] [Abstract][Full Text] [Related]
37. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
Anticancer Res; 2007; 27(5A):3035-44. PubMed ID: 17970042
[TBL] [Abstract][Full Text] [Related]
38. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
[TBL] [Abstract][Full Text] [Related]
39. Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.
Ahmad R; Raina D; Meyer C; Kharbanda S; Kufe D
J Biol Chem; 2006 Nov; 281(47):35764-9. PubMed ID: 16998237
[TBL] [Abstract][Full Text] [Related]
40. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.
Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C
Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]